$0
President and Director
2024
President and Director at Cystic Fibrosis Foundation Therapeutics Inc.
Fiscal year ended December 31, 2024. Published on January 25, 2026.
Total compensation
Michael P Boyle, M.D. has been listed as an employee of Cystic Fibrosis Foundation Therapeutics Inc. in Form 990 filings since at least fiscal year 2016. Total compensation for Michael P Boyle, M.D. has decreased by 100% from 2016 to 2024.